Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/174098
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMartínez Sánchez, Jose M.-
dc.contributor.authorBallbè i Gibernau, Montse-
dc.contributor.authorPérez Ortuño, Raúl-
dc.contributor.authorFu Balboa, Marcela-
dc.contributor.authorSureda, Xisca-
dc.contributor.authorPascual, José Antonio-
dc.contributor.authorPeruga, Armando-
dc.contributor.authorFernández Muñoz, Esteve-
dc.date.accessioned2021-02-19T11:34:01Z-
dc.date.available2021-02-19T11:34:01Z-
dc.date.issued2019-11-01-
dc.identifier.issn0213-9111-
dc.identifier.urihttp://hdl.handle.net/2445/174098-
dc.description.abstractObjective: to assess the levels of a tobacco-specific nitrosamine (NNAL) in non-smokers passively exposed to the second-hand aerosol (SHA) emitted from users of electronic cigarettes (e-cigarettes). Method: we conducted an observational study involving 55 non-smoking volunteers divided into three groups: 25 living at home with conventional smokers, 6 living with e-cigarette users, and 24 in control homes (smoke-free homes). We obtained urine samples from all volunteers to determine NNAL. Results: we detected NNAL in the urine of volunteers exposed to e-cigarettes (median:0.55 pg/mL; interquartile range: 0.26-2.94 pg/mL). The percentage of urine samples with quantifiable NNAL differed significantly among the three groups of homes: 29.2%, 66.7% and 76.0%, respectively (p=0.004). Conclusions: we found NNAL nitrosamine in urine samples from people exposed to SHA from e-cigarettes. However, these results could be confirmed with more studies with larger sample sizes.eng
dc.format.extent4 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoengeng
dc.publisherElsevier-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.gaceta.2018.07.016-
dc.relation.ispartofGaceta Sanitaria, 2019, vol. 33, num. 6, p. 575-578-
dc.relation.urihttps://doi.org/10.1016/j.gaceta.2018.07.016-
dc.rightscc-by-nc-nd (c) Sociedad Española de Salud Pública y Administración Sanitaria (SESPAS), 2019-
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es-
dc.sourceArticles publicats en revistes (Ciències Clíniques)-
dc.subject.classificationCigarretes electròniques-
dc.subject.classificationMarcadors bioquímics-
dc.subject.classificationNitrosamines-
dc.subject.otherElectronic cigarettes-
dc.subject.otherBiochemical markers-
dc.subject.otherNitrosoamines-
dc.titleSecondhand exposure to aerosol from electronic cigarettes: pilot study of assessment of tobacco-specific nitrosamine (NNAL) in urineeng
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec689306-
dc.date.updated2021-02-19T11:34:02Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
689306.pdf210.25 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons